Selecting the optimal cancer treatment with artificial intelligence

Each year, more people are being diagnosed with cancer. They will often receive a standardized medical treatment that disregards the patient’s expectations about their quality of life during and after treatment. The PersOn programme uses artificial intelligence to analyse all data available – of the type of cancer as well as the individual patient – to predict the expected outcome of various treatment options. Using this information, the clinician and the patient will jointly choose the personalised care path that maximises the probability of having the highest quality of life.

Programme leader:

Dr. Johan Kwisthout (Radboud University)

Participating knowledge institutes:

Amsterdam UMC, Eindhoven University of Technology, Maastricht University, Netherlands Comprehensive Cancer Organisation, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Open Universiteit, Radboud University, Radboudumc, TNO, Utrecht University, VU Amsterdam

‍